Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Rocket Pharmaceuticals, Inc.

NASDAQ: RCKT · Life Sciences · 6 alerts · CIK 1281895

Share price
$2.16Close, Nov 16
Market cap
$241M
Shares outstanding
111.66MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Rocket Pharmaceuticals, Inc. filings on SEC EDGAR ↗

7:07 AM ET 8-K
Business Update

Rocket Pharmaceuticals Business Update

Rocket Pharmaceuticals announced alignment with the FDA on the pivotal Phase 2 trial design for RP-A501 in Danon disease, including a 12-patient pivotal population and 12-month co-primary endpoints. The FDA's review of initial safety data from the first three patients supports continued enrollment and dosing under a modified protocol, with completion of dosing expected by mid-2027.

Counterparty
FDA

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.